# Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tofacitinib-cp-690-550-in-combination-with-methotrexate-in-patients-with-active/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gerd R Burmester,Ricardo Blanco,Christina Charles‐Schoeman,J. Wollenhaupt,Cristiano A. F. Zerbini,Birgitta Benda,David Gruben,Gene V. Wallenstein,Sriram Krishnaswami,Samuel H. Zwillich,Tamás Koncz,Koshika Soma,John Bradley,Charles A. Mebus |
| Citations | 725 |
| DOI | 10.1016/s0140-6736(12)61424-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2164858045 |
| PMID | 23294500 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Ricardo Blanco](https://scholariq.org/researchers/ricardo-blanco/)
- [David Gruben](https://scholariq.org/researchers/david-gruben/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.